镁在人类心血管疾病中的作用-国际临床研究杂志-CSCIED科技核心评价数据库-手机版

镁在人类心血管疾病中的作用

Deciphering the role for magnesium in cardiovascular diseases

ES评分 0 浏览量：1200 下载量：0

DOI	10.12208/j.ijcr.20240285
刊名	国际临床研究杂志 International Journal of Clinical Research
年，卷(期)	2024, 8(8)
作者	罗宇琦,任骏*,
作者单位	复旦大学上海医学院上海 ; 复旦大学附属中山医院心内科，上海市心血管病研究所上海 ;
摘要	镁是人体内含量第四高的阳离子，参与调节心血管功能的多个基本生理、生化和细胞过程。镁对于血管平滑肌细胞、内皮细胞和心肌细胞的正常功能至关重要。血清镁异常是高血压、动脉粥样硬化、冠状动脉疾病、心力衰竭和心律失常等多种发病机制中的关键因子，可能增加不良心血管事件的发生风险。本文旨在探讨镁在人类心血管病中的作用及其相关机制，并对镁的补充提供合理建议。
Abstract	Magnesium is the fourth most abundant cation in the human body and plays a significant role in several fundamental physiological, biochemical and cellular processes involved in the regulation of cardiovascular function. It is essential for the normal function of vascular smooth muscle cells, endothelial cells, and cardiomyocytes. Abnormal serum magnesium levels are a key factor in the pathogenesis of various cardiovascular conditions, including hypertension, atherosclerosis, coronary artery disease, heart failure and arrhythmias, and may increase the risk of adverse cardiovascular events. This mini-review aims to explore the role of magnesium and its associated mechanisms in human cardiovascular disease, hoping to provide rational recommendations for magnesium supplementation.
关键词	镁；心血管疾病；高血压；冠心病；心律失常
KeyWord	Magnesium; Cardiovascular disease; Hypertension; Coronary heart disease; Arrhythmia
基金项目
页码	1-8

参考文献
相关文献

[1] Health TWCotRoC, China Di. 中国心血管健康与疾病报告2022概要
[J]. 中国循环杂志, 2023, 38(06): 583-612.
[2] Mathew AA, Panonnummal R. 'Magnesium'-the master cation-as a drug-possibilities and evidences
[J]. Biometals, 2021, 34(5): 955-86.
[3] Yamanaka R, Shindo Y, Oka K. Magnesium Is a Key Player in Neuronal Maturation and Neuropathology
[J]. Int J Mol Sci, 2019, 20(14)
[4] Liu M, Dudley SC, Jr. Magnesium, Oxidative Stress, Inflammation, and Cardiovascular Disease
[J]. Antioxidants (Basel), 2020, 9(10)
[5] Qiao W, Wong KHM, Shen J, et al. TRPM7 kinase-mediated immunomodulation in macrophage plays a central role in magnesium ion-induced bone regeneration
[J]. Nat Commun, 2021, 12(1): 2885.
[6] Ritterhoff J, Tian R. Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges
[J]. Nat Rev Cardiol, 2023, 20(12): 812-29.
[7] Li M, Li Y, Lu Y, et al. Molecular basis of Mg(2+) permeation through the human mitochondrial Mrs2 channel
[J]. Nat Commun, 2023, 14(1): 4713.
[8] Uthayabalan S, Vishnu N, Madesh M, et al. The human MRS2 magnesium-binding domain is a regulatory feedback switch for channel activity
[J]. Life Sci Alliance, 2023, 6(4)
[9] Madaris TR, Venkatesan M, Maity S, et al. Limiting Mrs2-dependent mitochondrial Mg(2+) uptake induces metabolic programming in prolonged dietary stress
[J]. Cell Rep, 2023, 42(3): 112155.
[10] Lai LTF, Balaraman J, Zhou F, et al. Cryo-EM structures of human magnesium channel MRS2 reveal gating and regulatory mechanisms
[J]. Nat Commun, 2023, 14(1): 7207.
[11] Daw CC, Ramachandran K, Enslow BT, et al. Lactate Elicits ER-Mitochondrial Mg(2+) Dynamics to Integrate Cellular Metabolism
[J]. Cell, 2020, 183(2): 474-89.e17.
[12] Shahi A, Aslani S, Ataollahi M, et al. The role of magnesium in different inflammatory diseases
[J]. Inflammopharmacology, 2019, 27(4): 649-61.
[13] Maier JA, Castiglioni S, Locatelli L, et al. Magnesium and inflammation: Advances and perspectives
[J]. Semin Cell Dev Biol, 2021, 115: 37-44.
[14] Ashique S, Kumar S, Hussain A, et al. A narrative review on the role of magnesium in immune regulation, inflammation, infectious diseases, and cancer
[J]. J Health Popul Nutr, 2023, 42(1): 74.
[15] Zeng HL, Yang Q, Yuan P, et al. Associations of essential and toxic metals/metalloids in whole blood with both disease severity and mortality in patients with COVID-19
[J]. Faseb j, 2021, 35(3): e21392.
[16] Iotti S, Wolf F, Mazur A, et al. The COVID-19 pandemic: is there a role for magnesium? Hypotheses and perspectives
[J]. Magnes Res, 2020, 33(2): 21-7.
[17] Barbagallo M, Veronese N, Dominguez LJ. Magnesium in Aging, Health and Diseases
[J]. Nutrients, 2021, 13(2)
[18] Lötscher J, Martí ILAA, Kirchhammer N, et al. Magnesium sensing via LFA-1 regulates CD8(+) T cell effector function
[J]. Cell, 2022, 185(4): 585-602.e29.
[19] Dominguez LJ, Veronese N, Guerrero-Romero F, et al. Magnesium in Infectious Diseases in Older People
[J]. Nutrients, 2021, 13(1)
[20] Locatelli L, Fedele G, Castiglioni S, et al. Magnesium Deficiency Induces Lipid Accumulation in Vascular Endothelial Cells via Oxidative Stress-The Potential Contribution of EDF-1 and PPARγ
[J]. Int J Mol Sci, 2021, 22(3)
[21] Pitzer A, Elijovich F, Laffer CL, et al. DC ENaC-Dependent Inflammasome Activation Contributes to Salt-Sensitive Hypertension
[J]. Circ Res, 2022, 131(4): 328-44.
[22] Cai Z, Gong Z, Li Z, et al. Vascular Extracellular Matrix Remodeling and Hypertension
[J]. Antioxid Redox Signal, 2021, 34(10): 765-83.
[23] Fritzen R, Davies A, Veenhuizen M, et al. Magnesium Deficiency and Cardiometabolic Disease
[J]. Nutrients, 2023, 15(10)
[24] Izzi B, Tirozzi A, Cerletti C, et al. Beyond Haemostasis and Thrombosis: Platelets in Depression and Its Co-Morbidities
[J]. Int J Mol Sci, 2020, 21(22)
[25] Klavina PA, Leon G, Curtis AM, et al. Dysregulated haemostasis in thrombo-inflammatory disease
[J]. Clin Sci (Lond), 2022, 136(24): 1809-29.
[26] Ray E, Mohan K, Ahmad S, et al. Physiology of a Forgotten Electrolyte-Magnesium Disorders
[J]. Adv Kidney Dis Health, 2023, 30(2): 148-63.
[27] Rosanoff A, Costello RB, Johnson GH. Effectively Prescribing Oral Magnesium Therapy for Hypertension: A Categorized Systematic Review of 49 Clinical Trials
[J]. Nutrients, 2021, 13(1)
[28] Asbaghi O, Hosseini R, Boozari B, et al. The Effects of Magnesium Supplementation on Blood Pressure and Obesity Measure Among Type 2 Diabetes Patient: a Systematic Review and Meta-analysis of Randomized Controlled Trials
[J]. Biol Trace Elem Res, 2021, 199(2): 413-24.
[29] Banjanin N, Belojevic G. Changes of Blood Pressure and Hemodynamic Parameters after Oral Magnesium Supplementation in Patients with Essential Hypertension-An Intervention Study
[J]. Nutrients, 2018, 10(5)
[30] Vongpatanasin W, Giacona JM, Pittman D, et al. Potassium Magnesium Citrate Is Superior to Potassium Chloride in Reversing Metabolic Side Effects of Chlorthalidone
[J]. Hypertension, 2023, 80(12): 2611-20.
[31] AlShanableh Z, Ray EC. Magnesium in hypertension: mechanisms and clinical implications
[J]. Front Physiol, 2024, 15: 1363975.
[32] Pitzer Mutchler A, Huynh L, Patel R, et al. The role of dietary magnesium deficiency in inflammatory hypertension
[J]. Front Physiol, 2023, 14: 1167904.
[33] Elijovich F, Kleyman TR, Laffer CL, et al. Immune Mechanisms of Dietary Salt-Induced Hypertension and Kidney Disease: Harry Goldblatt Award for Early Career Investigators 2020
[J]. Hypertension, 2021, 78(2): 252-60.
[34] Nusca A, Viscusi MM, Piccirillo F, et al. In Stent Neo-Atherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches
[J]. Life (Basel), 2022, 12(3)
[35] Mohebi F, Ostadhadi S, Vaziri MS, et al. The effect of magnesium sulfate on gene expression and serum level of inflammatory cytokines in coronary artery disease patients
[J]. Inflammopharmacology, 2023, 31(5): 2421-30.
[36] Rahnama Inchehsablagh B, Ghadiri Soufi F, Koochakkhani S, et al. Magnesium Supplementation Affects the Expression of Sirtuin1, Tumor Protein P53 and Endothelial Nitric Oxide Synthase Genes in Patients with Atherosclerosis: A Double-Blind, Randomized, Placebo-Controlled Trial
[J]. Indian J Clin Biochem, 2023, 38(1): 59-66.
[37] Qi H, Ge T, Wang K, et al. Effect of High Magnesium and Astragaloside IV on Vascular Endothelial Cells
[J]. Cell Biochem Biophys, 2024,
[38] Farshidi H, Sobhani AR, Eslami M, et al. Magnesium Sulfate Administration in Moderate Coronary Artery Disease Patients Improves Atherosclerotic Risk Factors: A Double-Blind Clinical Trial Study
[J]. J Cardiovasc Pharmacol, 2020, 76(3): 321-8.
[39] Du W, Yan C, Wang Y, et al. Association between dietary magnesium intake and gallstones: the mediating role of atherogenic index of plasma
[J]. Lipids Health Dis, 2024, 23(1): 82.
[40] Xia J, Yin C. Glucose Variability and Coronary Artery Disease
[J]. Heart Lung Circ, 2019, 28(4): 553-9.
[41] Dong H, Hu P, Wang J, et al. Serum magnesium and calcium were inversely associated with hemoglobin glycation index and triglyceride-glucose index in adults with coronary artery disease
[J]. Biol Trace Elem Res, 2024,
[42] Bouillon-Minois JB, Khaled L, Vitte F, et al. Ionized Magnesium: Interpretation and Interest in Atrial Fibrillation
[J]. Nutrients, 2023, 15(1)
[43] Li L, Lutsey PL, Chen LY, et al. Circulating Magnesium and Risk of Major Adverse Cardiac Events among Patients with Atrial Fibrillation in the ARIC Cohort
[J]. Nutrients, 2023, 15(5)
[44] Ramesh T, Lee PYK, Mitta M, et al. Intravenous magnesium in the management of rapid atrial fibrillation: A systematic review and meta-analysis
[J]. J Cardiol, 2021, 78(5): 375-81.
[45] Hoffer M, Tran QK, Hodgson R, et al. Utility of magnesium sulfate in the treatment of rapid atrial fibrillation in the emergency department: a systematic review and meta-analysis
[J]. Eur J Emerg Med, 2022, 29(4): 253-61.
[46] Zaouche K, Mhadhbi H, Boubaker R, et al. Magnesium Sulfate: an adjunctive therapy in the first hour of management of rapid atrial fibrillation in the emergency department
[J]. Tunis Med, 2021, 99(2): 225-31.
[47] Tarleton EK. Factors influencing magnesium consumption among adults in the United States
[J]. Nutr Rev, 2018, 76(7): 526-38.
[48] 中国营养学会发布《2023版中国居民膳食营养素参考摄入量》
[J]. 营养学报, 2023, 45(05): 414.
[49] Lu L, Chen C, Yang K, et al. Magnesium intake is inversely associated with risk of obesity in a 30-year prospective follow-up study among American young adults
[J]. Eur J Nutr, 2020, 59(8): 3745-53.
[50] Al-Qaridhi A, Ghosh S, Luo D, et al. Magnesium and Zinc Intake Ratio Mediates the Increase of Coronary Artery Calcification through Upregulating Interleukin 6
[J]. Libyan J Med, 2022, 17(1): 2028997.
[51] Cazzola R, Della Porta M, Manoni M, et al. Going to the roots of reduced magnesium dietary intake: A tradeoff between climate changes and sources
[J]. Heliyon, 2020, 6(11): e05390.
[52] Liao M, Bai L, He L, et al. Associations of serum calcium/magnesium ratios with coronary artery disease in diabetes: a cross-sectional study
[J]. Postgrad Med, 2023, 135(1): 72-8.
[53] Uysal N, Kizildag S, Yuce Z, et al. Timeline (Bioavailability) of Magnesium Compounds in Hours: Which Magnesium Compound Works Best?
[J]. Biol Trace Elem Res, 2019, 187(1): 128-36.
[54] Ates M, Kizildag S, Yuksel O, et al. Dose-Dependent Absorption Profile of Different Magnesium Compounds
[J]. Biol Trace Elem Res, 2019, 192(2): 244-51.
[55] Bressendorff I, Hansen D, Schou M, et al. The Effect of Magnesium Supplementation on Vascular Calcification in CKD: A Randomized Clinical Trial (MAGiCAL-CKD)
[J]. J Am Soc Nephrol, 2023, 34(5): 886-94.
[56] Sakaguchi Y, Hamano T, Obi Y, et al. A Randomized Trial of Magnesium Oxide and Oral Carbon Adsorbent for Coronary Artery Calcification in Predialysis CKD
[J]. Journal of the American Society of Nephrology, 2019, 30(6): 1073-85.

引用本文

罗宇琦,任骏*. 镁在人类心血管疾病中的作用 [J]. 国际临床研究杂志. 2024; 8; (8). 1 - 8.

文献评论

相关学者

相关机构